Cover
Cover | Sep. 10, 2024 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Sep. 10, 2024 |
Entity File Number | 001-36033 |
Entity Registrant Name | THERAVANCE BIOPHARMA, INC. |
Entity Central Index Key | 0001583107 |
Entity Tax Identification Number | 98-1226628 |
Entity Incorporation, State or Country Code | E9 |
Entity Address, Address Line One | C/O Theravance Biopharma US, Inc. |
Entity Address, Address Line Two | 901 Gateway Boulevard |
Entity Address, City or Town | South San Francisco |
Entity Address, Country | CA |
Entity Address, Postal Zip Code | 94080 |
City Area Code | 650 |
Local Phone Number | 808-6000 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Ordinary Share $0.00001 Par Value |
Trading Symbol | TBPH |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |